Discussion
tumor, radionecrosis
ADVERSE EVENTS, BRAIN METASTASES, TUMOR
Currently, limiting the risk of adverse events such as radionecrosis is a major challenge in the treatment of brain metastases. fSRS potentially reduces this risk of radionecrosis and local tumor failure.